1.
Full Text
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
Lancet, The, ISSN 0140-6736, 08/2012, Volume 380, Issue 9841, pp. 572 - 580
Summary Background High plasma HDL cholesterol is associated with reduced risk of myocardial infarction, but whether this association is causal is unclear....
Internal Medicine | ENDOTHELIAL LIPASE | METAANALYSIS | BLOOD CHOLESTEROL | ATHEROSCLEROSIS | GENETIC-VARIANTS | LOCI | CORONARY-HEART-DISEASE | UMCG Approved | HIGH-DENSITY-LIPOPROTEIN | ISCHEMIC CARDIOVASCULAR-DISEASE | ARTERY-DISEASE | MEDICINE, GENERAL & INTERNAL | CONTRIBUTE | SUSCEPTIBILITY | CARDIOVASCULAR-DISEASE | ASSOCIATION | Mendelian Randomization Analysis - methods | Myocardial Infarction - blood | Myocardial Infarction - genetics | Genetic Predisposition to Disease | Myocardial Infarction - epidemiology | Prospective Studies | Gene Frequency | Humans | Risk Factors | Biomarkers - blood | Case-Control Studies | Cholesterol, HDL - blood | Cholesterol, LDL - blood | Polymorphism, Single Nucleotide | Myocardial Infarction - etiology | Lipase - genetics | Genetic aspects | High density lipoproteins | Health aspects | Heart attack | Risk factors | Studies | Plasma | Heart attacks | Diet | Cardiovascular disease | Lipids | Cholesterol | Medical and Health Sciences | Medicin och hälsovetenskap
Internal Medicine | ENDOTHELIAL LIPASE | METAANALYSIS | BLOOD CHOLESTEROL | ATHEROSCLEROSIS | GENETIC-VARIANTS | LOCI | CORONARY-HEART-DISEASE | UMCG Approved | HIGH-DENSITY-LIPOPROTEIN | ISCHEMIC CARDIOVASCULAR-DISEASE | ARTERY-DISEASE | MEDICINE, GENERAL & INTERNAL | CONTRIBUTE | SUSCEPTIBILITY | CARDIOVASCULAR-DISEASE | ASSOCIATION | Mendelian Randomization Analysis - methods | Myocardial Infarction - blood | Myocardial Infarction - genetics | Genetic Predisposition to Disease | Myocardial Infarction - epidemiology | Prospective Studies | Gene Frequency | Humans | Risk Factors | Biomarkers - blood | Case-Control Studies | Cholesterol, HDL - blood | Cholesterol, LDL - blood | Polymorphism, Single Nucleotide | Myocardial Infarction - etiology | Lipase - genetics | Genetic aspects | High density lipoproteins | Health aspects | Heart attack | Risk factors | Studies | Plasma | Heart attacks | Diet | Cardiovascular disease | Lipids | Cholesterol | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Journal of Minimally Invasive Gynecology, The, ISSN 1553-4650, 2016, Volume 23, Issue 3, pp. 303 - 308
Journal Article
Heart Rhythm, ISSN 1547-5271, 2017, Volume 14, Issue 7, pp. e97 - e153
(21) Mayo Clinic, Phoenix, AZ
Cardiovascular | Cardiac pacemakers | Radiation therapy | Magnetic resonance imaging | Computed tomography imaging | Implantable cardioverter defibrillators | PERMANENT PACEMAKERS | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIAC-RHYTHM DEVICES | LATEST GENERATION | COMPUTED-TOMOGRAPHY | PROMRI PACEMAKER SYSTEM | CARDIOVERTER-DEFIBRILLATORS | CANCER-PATIENTS | IN-VITRO EVALUATION | CLINICAL SAFETY | 1.5 TESLA | Medical colleges | Care and treatment | Heart beat | Implants, Artificial | Prosthesis | Cardiac patients | Environmental health | Radiation
Cardiovascular | Cardiac pacemakers | Radiation therapy | Magnetic resonance imaging | Computed tomography imaging | Implantable cardioverter defibrillators | PERMANENT PACEMAKERS | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIAC-RHYTHM DEVICES | LATEST GENERATION | COMPUTED-TOMOGRAPHY | PROMRI PACEMAKER SYSTEM | CARDIOVERTER-DEFIBRILLATORS | CANCER-PATIENTS | IN-VITRO EVALUATION | CLINICAL SAFETY | 1.5 TESLA | Medical colleges | Care and treatment | Heart beat | Implants, Artificial | Prosthesis | Cardiac patients | Environmental health | Radiation
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 57, Issue 20, pp. 2000 - 2007
Objectives The aim of this study was to test the effects of the KIF6 Trp719Arg polymorphism (rs20455) on vascular risk and response to statin therapy in 18,348...
Cardiovascular | Internal Medicine | KIF6 | statin response | vascular risk | pharmacogenetics | CARDIAC & CARDIOVASCULAR SYSTEMS | KINESIN-LIKE PROTEIN-6 | MYOCARDIAL-INFARCTION | ATHEROSCLEROSIS RISK | TRP719ARG POLYMORPHISM | GENE VARIANTS | THERAPY | ISCHEMIC-STROKE | ASSOCIATION | CORONARY-ARTERY-DISEASE | SINGLE NUCLEOTIDE POLYMORPHISMS | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Risk Factors | Genotype | Male | Treatment Outcome | Cardiovascular Diseases - enzymology | Cardiovascular Diseases - genetics | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Aged, 80 and over | Kinesin - genetics | Adult | Female | Polymorphism, Genetic - genetics | Aged | Medical research | Pharmacogenetics | Low density lipoproteins | Cardiac patients | Medicine, Experimental | Clinical trials | Genetic aspects | Heart attack | Statins | Cholesterol | Cardiovascular agents
Cardiovascular | Internal Medicine | KIF6 | statin response | vascular risk | pharmacogenetics | CARDIAC & CARDIOVASCULAR SYSTEMS | KINESIN-LIKE PROTEIN-6 | MYOCARDIAL-INFARCTION | ATHEROSCLEROSIS RISK | TRP719ARG POLYMORPHISM | GENE VARIANTS | THERAPY | ISCHEMIC-STROKE | ASSOCIATION | CORONARY-ARTERY-DISEASE | SINGLE NUCLEOTIDE POLYMORPHISMS | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Risk Factors | Genotype | Male | Treatment Outcome | Cardiovascular Diseases - enzymology | Cardiovascular Diseases - genetics | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Aged, 80 and over | Kinesin - genetics | Adult | Female | Polymorphism, Genetic - genetics | Aged | Medical research | Pharmacogenetics | Low density lipoproteins | Cardiac patients | Medicine, Experimental | Clinical trials | Genetic aspects | Heart attack | Statins | Cholesterol | Cardiovascular agents
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 69, Issue 4, pp. 381 - 391
Abstract Background Symptomatic mitral regurgitation (MR) is associated with high morbidity and mortality that can be ameliorated by surgical valve repair or...
Cardiovascular | Internal Medicine | heart failure | mitral valve implantation | transcatheter | mitral regurgitation | mitral prosthesis | Health aspects | Care and treatment | Mitral valve insufficiency
Cardiovascular | Internal Medicine | heart failure | mitral valve implantation | transcatheter | mitral regurgitation | mitral prosthesis | Health aspects | Care and treatment | Mitral valve insufficiency
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 2, pp. 230 - 231
Cardiovascular | Internal Medicine | Genetic Predisposition to Disease | Stroke - prevention & control | Humans | Middle Aged | Coronary Disease - etiology | Benzaldehydes - pharmacology | Male | Arterial Occlusive Diseases - genetics | Phospholipase A2 Inhibitors - pharmacology | Coronary Disease - prevention & control | Stroke - etiology | Stroke - metabolism | 1-Alkyl-2-acetylglycerophosphocholine Esterase - genetics | Coronary Disease - metabolism | Arterial Occlusive Diseases - drug therapy | Arterial Occlusive Diseases - metabolism | China | Oximes - pharmacology | Female | Arterial Occlusive Diseases - complications | Letters
Journal Article
Ophthalmology, ISSN 0161-6420, 2009, Volume 116, Issue 11, pp. 2188 - 2198.e1
Purpose To evaluate the outcome of treatment with methotrexate for noninfectious ocular inflammation. Design Retrospective cohort study. Participants Patients...
Ophthalmology | LOW-DOSE METHOTREXATE | IMMUNOSUPPRESSIVE THERAPY | INTRAOCULAR LEVELS | CORTICOSTEROID-SPARING THERAPY | JUVENILE RHEUMATOID-ARTHRITIS | INDUCED PNEUMONITIS | CHRONIC UVEITIS | OPHTHALMOLOGY | IDIOPATHIC ARTHRITIS | OPTIC NEUROPATHY | TOXICITY | Uveitis - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Child, Preschool | Pemphigoid, Benign Mucous Membrane - drug therapy | Male | Treatment Outcome | Methotrexate - therapeutic use | Visual Acuity | Conjunctival Diseases - drug therapy | Inflammation - drug therapy | Adolescent | Scleritis - drug therapy | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Child | Methotrexate | Medical colleges
Ophthalmology | LOW-DOSE METHOTREXATE | IMMUNOSUPPRESSIVE THERAPY | INTRAOCULAR LEVELS | CORTICOSTEROID-SPARING THERAPY | JUVENILE RHEUMATOID-ARTHRITIS | INDUCED PNEUMONITIS | CHRONIC UVEITIS | OPHTHALMOLOGY | IDIOPATHIC ARTHRITIS | OPTIC NEUROPATHY | TOXICITY | Uveitis - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Child, Preschool | Pemphigoid, Benign Mucous Membrane - drug therapy | Male | Treatment Outcome | Methotrexate - therapeutic use | Visual Acuity | Conjunctival Diseases - drug therapy | Inflammation - drug therapy | Adolescent | Scleritis - drug therapy | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Child | Methotrexate | Medical colleges
Journal Article
Journal of Critical Care, ISSN 0883-9441, 2013, Volume 28, Issue 1, pp. 28 - 39
Abstract Background Successful completion of randomized trials depends upon efficiently and ethically screening patients and obtaining informed consent....
Critical Care | Studies | Critical care | Informed consent | Clinical research | Intensive care | Randomized trials | RECRUITMENT | FAMILY-MEMBERS | ENROLLMENT | SURROGATE DECISION-MAKERS | INTENSIVE-CARE-UNIT | RECOMMENDATIONS | PREFERENCES | CLINICAL-TRIALS | CRITICALLY-ILL PATIENTS | PARTICIPATION | CRITICAL CARE MEDICINE | Multivariate Analysis | Intensive Care Units | Guideline Adherence | Thromboembolism - prevention & control | Humans | Randomized Controlled Trials as Topic - ethics | Informed Consent - ethics | Logistic Models | Vulnerable Populations | Organizational Case Studies | Case studies | Informed consent (Medical law)
Critical Care | Studies | Critical care | Informed consent | Clinical research | Intensive care | Randomized trials | RECRUITMENT | FAMILY-MEMBERS | ENROLLMENT | SURROGATE DECISION-MAKERS | INTENSIVE-CARE-UNIT | RECOMMENDATIONS | PREFERENCES | CLINICAL-TRIALS | CRITICALLY-ILL PATIENTS | PARTICIPATION | CRITICAL CARE MEDICINE | Multivariate Analysis | Intensive Care Units | Guideline Adherence | Thromboembolism - prevention & control | Humans | Randomized Controlled Trials as Topic - ethics | Informed Consent - ethics | Logistic Models | Vulnerable Populations | Organizational Case Studies | Case studies | Informed consent (Medical law)
Journal Article